Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
CMA
|
James Mcgregor Carr
Executive Vice Pres. |
SELL
Payment of exercise price or tax liability
|
Direct | 428 Reduced 1.13% |
$25,277
$59.06 p/Share
|
Mar 31
2025 |
|
FOR
|
Samuel R Fuller
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 911 Added 3.22% |
-
|
Mar 31
2025 |
|
FOR
|
Lisa H. Jamieson
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 911 Added 4.0% |
-
|
Mar 31
2025 |
|
FOR
|
James Douglas Allen
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 911 Reduced 1.83% |
$19,258
$21.14 p/Share
|
Mar 31
2025 |
|
FOR
|
James Douglas Allen
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 4,504 Added 8.29% |
-
|
Mar 31
2025 |
|
RPRX
|
Henry A Fernandez
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,141 Added 1.97% |
$37,504
$32.87 p/Share
|
Mar 31
2025 |
|
RPRX
|
Bonnie L Bassler
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,141 Added 1.79% |
$37,504
$32.87 p/Share
|
Mar 31
2025 |
|
BKSY
|
Susan M. Gordon
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,910 Added 4.38% |
-
|
Mar 31
2025 |
|
MGRC
|
Gilda Malek
SVP, Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 1,430 Added 20.91% |
-
|
Mar 31
2025 |
|
MGRC
|
Gilda Malek
SVP, Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 512 Reduced 9.47% |
$57,036
$111.4 p/Share
|
Mar 31
2025 |
|
BKSY
|
William D. Porteous
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,910 Added 4.39% |
-
|
Mar 31
2025 |
|
SLDP
|
John C. Van Scoter
President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 42,841 Reduced 3.27% |
$46,268
$1.08 p/Share
|
Mar 31
2025 |
|
PBPB
|
Robert D. Wright
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 2,182 Reduced 0.28% |
$20,750
$9.51 p/Share
|
Mar 31
2025 |
|
OSBC
|
Bradley S. Adams
CFO & COO |
BUY
Other acquisition or disposition
|
Indirect | 31 Added 0.0% |
-
|
Mar 31
2025 |
|
BKSY
|
Magid M Abraham
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,910 Added 5.31% |
-
|
Mar 31
2025 |
|
PFHC
|
Matthew A Greenwood
Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 3,576 Reduced 2.27% |
-
|
Mar 31
2025 |
|
PFHC
|
Matthew A Greenwood
Chief Commercial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct | 11,104 Reduced 7.21% |
$84,279
$7.59 p/Share
|
Mar 31
2025 |
|
PFHC
|
Matthew Wilks
Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct | 2,657 Reduced 0.17% |
-
|
Mar 31
2025 |
|
PFHC
|
Matthew Wilks
Executive Chairman |
SELL
Sale (or disposition) back to the issuer
|
Direct | 8,254 Reduced 0.52% |
$62,647
$7.59 p/Share
|
Mar 31
2025 |
|
PFHC
|
Johnathan Ladd Wilks
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 2,470 Reduced 1.01% |
-
|
Mar 31
2025 |
|
PFHC
|
Johnathan Ladd Wilks
Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct | 7,673 Reduced 3.18% |
$58,238
$7.59 p/Share
|
Mar 31
2025 |
|
NOC
|
Marianne Catherine Brown
Director |
BUY
Grant, award, or other acquisition
|
Direct | 90 Added 0.88% |
$46,080
$512.01 p/Share
|
Mar 31
2025 |
|
NOC
|
Arvind Krishna
Director |
BUY
Grant, award, or other acquisition
|
Direct | 71 Added 4.13% |
$36,352
$512.01 p/Share
|
Mar 31
2025 |
|
SLDP
|
James Liebscher
Chief Legal Officer & Sec |
SELL
Payment of exercise price or tax liability
|
Direct | 18,179 Reduced 2.63% |
$19,633
$1.08 p/Share
|
Mar 31
2025 |
|
NOC
|
Graham Robinson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 43 Added 2.12% |
$22,016
$512.01 p/Share
|
Mar 31
2025 |
|
SUNS
|
Leonard M Tannenbaum
Executive Chairman |
BUY
Open market or private purchase
|
Direct | 44,065 Added 1.6% |
$479,867
$10.89 p/Share
|
Mar 31
2025 |
|
BKSY
|
James R Tolonen
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,910 Added 4.39% |
-
|
Mar 31
2025 |
|
MDU
|
Marian M Durkin
Director |
BUY
Grant, award, or other acquisition
|
Direct | 165 Added 4.42% |
-
|
Mar 31
2025 |
|
SLDP
|
Joshua Buettner Garrett
Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 14,285 Reduced 1.73% |
$15,427
$1.08 p/Share
|
Mar 31
2025 |
|
SNX
|
John Paul Henry
Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 164 Reduced 0.8% |
$17,049
$103.96 p/Share
|
Mar 31
2025 |
|
SNX
|
David R Vetter
Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 923 Reduced 1.34% |
$95,955
$103.96 p/Share
|
Mar 31
2025 |
|
STSS
|
Robert Michael Hayes
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 125,000 Added 23.77% |
$3,750
$0.03 p/Share
|
Mar 31
2025 |
|
OSBC
|
Donald Pilmer
EVP |
BUY
Other acquisition or disposition
|
Indirect | 12 Added 0.0% |
-
|
Mar 31
2025 |
|
MDU
|
Vernon A. Dosch
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,650 Added 27.9% |
-
|
Mar 31
2025 |
|
CIA
|
Harvey J. Waite
Chief Actuary |
SELL
Payment of exercise price or tax liability
|
Direct | 3,833 Reduced 4.64% |
$17,440
$4.55 p/Share
|
Mar 31
2025 |
|
CIA
|
Harvey J. Waite
Chief Actuary |
BUY
Exercise of conversion of derivative security
|
Direct | 13,450 Added 14.26% |
-
|
Mar 31
2025 |
|
BRID
|
Allan Bridgford Jr. |
BUY
Open market or private purchase
|
Direct | 300 Added 0.66% |
$2,502
$8.34 p/Share
|
Mar 31
2025 |
|
EXPI
|
Monica Weakley |
BUY
Grant, award, or other acquisition
|
Direct | 144 Added 1.75% |
$1,382
$9.6 p/Share
|
Mar 31
2025 |
|
FENC
|
Robert Andrade
CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 1,042 Added 0.78% |
-
|
Mar 31
2025 |
|
FENC
|
Rosty Raykov |
BUY
Grant, award, or other acquisition
|
Direct | 2,431 Added 3.3% |
-
|
Mar 31
2025 |
|
SNX
|
Patrick Zammit
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 509 Reduced 0.31% |
$52,915
$103.96 p/Share
|
Mar 31
2025 |
|
NRG
|
Rasesh M. Patel
President, NRG Consumer |
SELL
Payment of exercise price or tax liability
|
Direct | 4,009 Reduced 2.31% |
$382,699
$95.46 p/Share
|
Mar 31
2025 |
|
URI
|
Marc A Bruno |
BUY
Grant, award, or other acquisition
|
Direct | 48 Added 0.68% |
$30,081
$626.7 p/Share
|
Mar 31
2025 |
|
SYY
|
Larry C Glasscock
Director |
BUY
Grant, award, or other acquisition
|
Direct | 353 Added 0.37% |
$26,157
$74.1 p/Share
|
Mar 31
2025 |
|
CIA
|
Jeffery P. Conklin
CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct | 17,515 Added 9.25% |
-
|
Mar 31
2025 |
|
CIA
|
Jeffery P. Conklin
CFO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct | 4,266 Reduced 2.46% |
$19,410
$4.55 p/Share
|
Mar 31
2025 |
|
GLXZ
|
Bryan W. Waters |
BUY
Grant, award, or other acquisition
|
Indirect | 4,452 Added 0.0% |
$12,643
$2.84 p/Share
|
Mar 31
2025 |
|
SYY
|
Alison Kenney Paul
Director |
BUY
Grant, award, or other acquisition
|
Direct | 111 Added 1.15% |
$8,225
$74.1 p/Share
|
Mar 31
2025 |
|
CIA
|
Robert M Mauldin Iii
VP, Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 18,855 Added 11.5% |
-
|
Mar 31
2025 |
|
SYY
|
Daniel J Brutto
Director |
BUY
Grant, award, or other acquisition
|
Direct | 67 Added 0.19% |
$4,964
$74.1 p/Share
|
Mar 31
2025 |